The device was not returned for analysis.
A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.
Based on the available information, the reported atrial perforation appears to have been a result of a combination of procedural and patient conditions.
The reported patient effect of atrial perforation as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.
The reported unexpected medical intervention was a result of case-specific circumstances.
There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report atrial perforation it was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4.
One clip was successfully implanted, reducing mr to a grade of 1.
However, after the steerable guide catheter (sgc) was removed, an atrial septal defect (asd) was observed causing a right to left shunt.
To treat the asd, an amplatzer device was successfully implanted.
There as no clinically significant delay in the procedure.
No additional information was provided.
|